The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Geraldine Ong, MD, MSc, an esteemed cardiologist and clinical investigator specializing in in the diagnosis and management of ...

A heart murmur is a sound often characterized as a "whooshing" or rushing of fluid that can be heard between heartbeats. As ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis, a valvular heart condition that can be deadly ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology’s (ACC) Annual Scientific Session & Expo, addressing the ...

Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Aortic stenosis is a condition where the aortic valve narrows, obstructing blood flow from the heart to the aorta. As a result, the heart must work harder to pump blood, causing increased pressure ...

Aortic stenosis is a disease often diagnosed in its asymptomatic phase due to its distinct murmur and the widespread use of noninvasive imaging. The history, however, is still of paramount ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Her expertise spans heart valve disease, aortic and connective tissue disorders ... She then pursued a Level III echocardiography fellowship at St. Michael's Hospital, followed by an ...